Although not significant, the mean NOS3 relative levels was four times higher in PCa in relation to BPH patients (ratio NOS3 mRNA/B2M mRNA: 2.23 and 0.50, respectively) (Figure 3B). The gene discussed is NOS3; the disease is benign prostatic hyperplasia.